Lorenz is the Chair of Pharmaceutics and Biopharmaceutics at the University of Würzburg. He holds a Habilitation and Dr. sc. nat. (awarded with the silver medal) from ETH Zürich and a Dr. rer. med. (summa cum laude) from the University of Frankfurt. Lorenz’ research interest are on enzymatically engineered drug depots, drug delivery of therapeutic gases, and oral delivery of poorly water soluble drug substances. Lorenz served as dean of his faculty from 2017-2019. He also holds an adjunct professorship at the department of bioengineering at Tufts University, Medford, MA, and he is chair at the expert group for pharmaceutical polymers at the European Pharmacopeia/EDQM.
Tessa joined the group in February ´11. She studied biochemistry at the University of Leipzig and accomplished her PhD 2009 in the group of Heike Hall at ETH Zurich (Department of Materials). During her thesis she aimed to improve nerve regeneration in the peripheral nervous system by diverse in vitro approaches in order to direct cellular growth by modified nanofibers and covalently attached guidance cues in fibrin gels. She also gained interest in polymeric non-viral gene delivery systems, which might help to provide growth factors and/or guidance cues in (re)generative tissues.
With a specific interest in regenerative medicine Tessa`s present research focuses on novel engineered proteins with enhanced pharmakokinetc properties, biomaterial design for tissue engineering and analytical techniques for the evaluation of protein stability at the molecular level.
Maximilian Richter studied pharmacy at Heidelberg University from 2011 to 2015. During his practical year in November 2015 he joined the lab of Carsten Erhardt at Trinitys College Dublin where he worked on evaluating the effects of cigarette smoke on a cellular level. After acquiring the licence to practice pharmacy in December 2016, he started his PhD in the field of pharmaceutical technology at the Helmholtz Institute for Pharmaceutical Research Saarland in the group of Gregor Fuhrmann. During his PhD from March 2017 till January 2021 he focused on chemical surface engineering of extracellular vesicles and the optimization of their long-term storage as important aspects for their future clinical translation. He joined the Chair for Drug Formulation and Delivery as a postdoctoral researcher in April 2021.
Kirstin Meiners studied pharmacy at Würzburg University from 2015 to 2019. During her practical year at Merck Healthcare, she gained experience at the analytical development of active ingredients and pharmaceutical intermediates. She received her license of practice pharmacy in November 2020 and since February 2021, she joined the Chair for Drug Formulation and Delivery at Würzburg University as a PhD student.